Neoplasia/BPH

	The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and cancer-specific survival of major urological cancers: An observational study. Medicine (Baltimore) Wang M, Jia K, Wang Y, Yuan D, Huang L, Li K, Zhong X. PMID: 42175471 [PubMed - indexed for MEDLINE]
	How Good Are Patient-Facing LLMs at Survivorship Questions? A Comparative User Evaluation Across Four Chatbots. Stud Health Technol Inform Khairat S, Masoumi S, Mehraby H, Geracitano J. PMID: 42175007 [PubMed - indexed for MEDLINE]
	Representation of Ordinal Features: Supervised Embeddings in the Survival Prediction of Prostate Cancer Patients. Stud Health Technol Inform Schwarz L. PMID: 42174784 [PubMed - indexed for MEDLINE]
	Pomegranate in Cancer Therapy: A Review of Anticancer Potential, Mechanisms and Clinical Challenges in Breast, Colon and Prostate Cancers. Phytother Res Kitic D, Miladinovic B, Randjelovic M, Szopa A, Seidel V, Sharifi-Rad J, Setzer WN, Calina D. PMID: 42174764 [PubMed - as supplied by publisher]
	IL20RB as a potential biomarker for prognosis in clear cell renal cell carcinoma. BMC Cancer Yuehua L, Dong X, Guiqiang L, Feiqiang R, Bin X, Wei T, Jie W, Yu G. PMID: 42174479 [PubMed - as supplied by publisher]
	Integrating lifestyle and clinical data in prostate cancer: expert assessment of a questionnaire. World J Urol Leitão C, Monteiro L, Fardilha M, Roque F, Herdeiro MT. PMID: 42174308 [PubMed - indexed for MEDLINE]
	Global research trends and thematic evolution in robot-assisted radical nephrectomy: a bibliometric and visualisation study. J Robot Surg Qiu Z, Duan C, Chen K, Yin C. PMID: 42174280 [PubMed - indexed for MEDLINE]
	Omission of indwelling urinary catheter after robotic partial nephrectomy in female patients: a single-surgeon experience. J Robot Surg Choi JW, Saxena S, Rajendran P, Kourouma A, Billah MS, Ahmed M. PMID: 42174186 [PubMed - indexed for MEDLINE]
	Early-access Use of Radioligand Therapy in Prostate Cancer. Eur Urol Focus François C, Bailly C. PMID: 42173792 [PubMed - as supplied by publisher]
	Comment on "Association of cardiovascular-kidney-metabolic syndrome with cardiovascular, cancer, and all-cause mortality among US adults: A prospective study". J Formos Med Assoc Shubham, Mathur A. PMID: 42173781 [PubMed - as supplied by publisher]
	Epigenetic signatures and risk determinants in bladder cancer: Implications for diagnostic and therapeutic interventions. Urol Oncol Pradhan B, Mishra P, Dash P, Niharika, Baral T, Mishra J, Chakraborty S, Nandi P, Patra SK. PMID: 42173769 [PubMed - as supplied by publisher]
	Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial. Prev Med Joung HH, Martin DN, Jones RA. PMID: 42173201 [PubMed - as supplied by publisher]
	Prostate imaging after focal ablation scoring after irreversible electroporation treatment in localized prostate cancer: Diagnostic accuracy and inter-reader agreement. Eur J Radiol Altan SA, Sakar R, Onay A, Kizil PG, Mercan ED, Gunhan O, Adsan O. PMID: 42172740 [PubMed - as supplied by publisher]
	Environmental Nonessential Element Exposure and Urologic Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open Deng Z, Li J, Ji R, Delgado JR, Yim SHL, Kachuri L, Cardenas A, Graff RE, Leppert JT, Dennis LK, Chung BI, Langston ME. PMID: 42172026 [PubMed - indexed for MEDLINE]
	TFPI2 expression predicts resistance to immunotherapy plus tyrosine kinase inhibitor and informs first-line therapy selection in metastatic renal cell carcinoma. Cell Oncol (Dordr) Wang J, Du L, Wang Y, Wang H, Zhu Y, Xu X. PMID: 42171882 [PubMed - as supplied by publisher]
	Renal function outcomes following endoscopic management of upper tract urothelial carcinoma. World J Urol Korn P, Essien M, Pallauf M, Cheaib J, Lokeshwar S, Herrera-Caceres JO, Small A, Raskolnikov D, Kleinmann N, Shvero A, Matin SF, Labbate C, Kaimakliotis H, Tachibana I, Linehan J, Choe J, Shah O, Movassaghi M, Huang W, Persily J, Perecman A, Canes D, Pessoa RR, Potretzke A, Raman JD, Singla N. PMID: 42171772 [PubMed - indexed for MEDLINE]
	Perirectal spacers and endorectal balloons in external beam radiotherapy for prostate cancer: aÂ review of prospective studies. Strahlenther Onkol Moll M, Mendenhall NP, Goldner G, Miszczyk M, Sushant S, Lütgendorf-Caucig C, Hug E, Mendenhall WM. PMID: 42171762 [PubMed - as supplied by publisher]
	First-Line Systemic Treatments for Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-analysis. J Urol Miyajima K, Miszczyk M, Matsukawa A, Roessler N, Inoue S, Urabe F, Mori K, Yanagisawa T, Karakiewicz PI, Agarwal N, Briganti A, Kimura T, Shariat SF. PMID: 42171515 [PubMed - as supplied by publisher]
	Interplay of the 3D genome and epigenome in androgen-driven prostate cancer. Epigenomics Campbell EM, Challis D, Clark SJ, Achinger-Kawecka J. PMID: 42170760 [PubMed - as supplied by publisher]
	Effects of neoadjuvant novel endocrine therapy combined with prostatic artery embolization on SII, PNI, and bRFS in patients with prostate cancer. Am J Transl Res Zhao B, Li B, Jiang J, Ma Q, Zhang H, You J, Li K. PMID: 42170485 [PubMed]

Articles 1 - 20 / 188061

Page 1 of 9404



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy